172 related articles for article (PubMed ID: 31448222)
1. Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma.
Li W; Xu L; Han J; Yuan K; Wu H
Front Oncol; 2019; 9():664. PubMed ID: 31448222
[No Abstract] [Full Text] [Related]
2. Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance.
Li W; Han J; Yuan K; Wu H
Aging (Albany NY); 2019 Jul; 11(13):4478-4509. PubMed ID: 31299011
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Xie H; Fu Q; Dai B; Ye D; Xu J
Clin Cancer Res; 2018 Jul; 24(13):3069-3078. PubMed ID: 29514839
[No Abstract] [Full Text] [Related]
4. Identification of
Shi M; Wang Y; Tang W; Cui X; Wu H; Tang Y; Wang P; Wu W; Zhang H
Ann Transl Med; 2020 Mar; 8(6):321. PubMed ID: 32355765
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures.
Ji F; Yuan JM; Gao HF; Xu AQ; Yang Z; Yang CQ; Zhang LL; Yang M; Li JQ; Zhu T; Cheng MY; Wu SY; Wang K
Front Mol Biosci; 2021; 8():759495. PubMed ID: 34708079
[TBL] [Abstract][Full Text] [Related]
6. A Novel Immunotype-based Risk Stratification Model Predicts Postoperative Prognosis and Adjuvant TACE Benefit in Chinese Patients with Hepatocellular Carcinoma.
Li TE; Zhang Z; Wang Y; Xu D; Dong J; Zhu Y; Wang Z
J Cancer; 2021; 12(10):2866-2876. PubMed ID: 33854587
[No Abstract] [Full Text] [Related]
7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
8. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
9. Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Zhao E; Chen S; Dang Y
Front Mol Biosci; 2020; 7():620765. PubMed ID: 33553243
[No Abstract] [Full Text] [Related]
10. A classification based on tumor budding and immune score for patients with hepatocellular carcinoma.
Wei L; Delin Z; Kefei Y; Hong W; Jiwei H; Yange Z
Oncoimmunology; 2020; 9(1):1672495. PubMed ID: 32002283
[No Abstract] [Full Text] [Related]
11. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
12. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
13. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
14. In-depth characterization of the biomarkers based on tumor-infiltrated immune cells reveals implications for diagnosis and prognosis in hepatocellular carcinoma.
Chen W; Bi K; Zhang X; Jiang J; Diao H
J Transl Autoimmun; 2020; 3():100067. PubMed ID: 33073226
[TBL] [Abstract][Full Text] [Related]
15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
16. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.
Xu L; Li L; Wang P; Zhang M; Zhang Y; Hao X; Yan L; Li B; Wen T; Xu M
Gut Liver; 2019 Nov; 13(6):669-682. PubMed ID: 30970430
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
Chen W; Ou M; Tang D; Dai Y; Du W
J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
[TBL] [Abstract][Full Text] [Related]
18. Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
Zhang J; Chen G; Zhang J; Zhang P; Ye Y
Am J Transl Res; 2020; 12(9):5108-5130. PubMed ID: 33042409
[TBL] [Abstract][Full Text] [Related]
19. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.
Tian MX; Liu WR; Wang H; Zhou YF; Jin L; Jiang XF; Tao CY; Tang Z; Zhou PY; Fang Y; Qu WF; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Lau WY; Fan J; Shi YH
BMC Med; 2019 Jun; 17(1):106. PubMed ID: 31164128
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
